DASA3DIAGNOSTICOS DA AMERICA S.A.Company Data · 2T26updated 2026-08-24
1
Overview
4T10 — 2T26 · 63 quarters
▼
DIAGNOSTICOS DA AMERICA S.A.
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments. It also offers medical, property and vehicle rental, consultancy, and franchise contracting services. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in São Paulo, Brazil.
SectorServiços médicos
Company HeadquartersSão Paulo, SP
Full Time Employees26.255
CEOMr. Rafael Lucchesi
Listing SegmentNovo Mercado
Foundation1966
Customer Rating—
Employee Rating—
Estrutura Acionária
21%Free Float
Fundo de Investimento em Participações Genoma III - Multiestratégia51%
Fundo De Investimento Em Participações Genoma Ii - Multiestratégia14%
1122-Sf Fundo De Investimento Em Ação5%
Genoma Pg Fundo De Investimento Em Ações5%
Banco Btg Pactual S/A5%
Free Float21%
Valuation
| Price | R$ 2,58 |
| Shares Outstanding | 1.249.824 |
| Market Capitalization | 3.225 |
| ( - ) Cash & Equivalents | 959 |
| ( + ) Total Debt | 6.158 |
| ( = ) Enterprise Value | 8.424 |
| P/E | — |
| EV / EBITDA | 5,3x |
R$ 2,58
Adj close · daily
Income Statement
| Revenue | 9.324 |
| EBITDA | 1.599 |
| EBIT | 636 |
| Net Income | (879) |
| SG&A % | (19,1%) |
Balance Sheet
| Assets | 17.123 |
| Cash | 959 |
| Total Debt | 6.158 |
| Net Debt | 5.200 |
| Fixed Assets | 6.840 |
| Working Capital | 1.578 |
| Equity | 6.866 |
Invested Capital & Reinvestment
| Invested Capital Turnover | 0,65x |
| Marginal IC Turnover | 0,41x |
| Reinvestment % NOPAT | (296,7%) |
| Working Capital Turnover | 7,42x |
| Cash Conv. Cycle | 55,9 |
| Fixed Assets Turnover | 1,28x |
| D&A % Fixed Assets | 12,4% |
| Capex % Revenue | 2,6% |
5,9 %
RoIC · LTM
RoIC (LTM)
Margins & Returns
| Revenue Growth | (33,1%) |
| Gross Margin | 31,0% |
| EBITDA Margin | 17,2% |
| Net Income Margin | (9,4%) |
| Effective Tax Rate | (26,1%) |
| Operating Leverage | 1,50x |
| RoIC | 5,9% |
| RoE | (12,3%) |
Capital Structure
| Current Ratio | 1,27x |
| Financial Leverage | 2,49x |
| Asset Turnover | 0,50x |
| Net Debt / EBITDA | 3,25x |
| Net Debt & Lease / EBITDA | 4,01x |
Cash Flow
| CFO Conversion | 93,7% |
| FCFF Yield | 33,2% |
| FCFE Yield | (2,6%) |
| Payout Ratio | (0,5%) |
| Dividend Yield | 0,1% |
| Interest % FCFF | 34,8% |
Latest CVM filings
- 2026-08-13reported 2T26
- 2026-05-12reported 1T26
- 2026-03-26reported 4T25
- 2025-11-13reported 3T25
- 2025-08-14reported 2T25
- 2025-05-14reported 1T25